Patent · US Active

Antibodies to CD70

US11434298B2 · kind B2 · utility

1Cited by

28References

11Claims

0Family size

Assignee

argenx BV · BE

Inventors

Karen Silence · Overijse, BE
Peter Ulrichts · Breda, NL
Johannes Joseph Wilhelmus De Haard · Vlaardingen, NL
Torsten Dreier · Breda, NL
Michael John Scott Saunders · Wondelgem, BE
Harald Wajant · Echterdingen, DE
Sofie Maria Elvire Gabriels · Zottegem, BE
Mahan Moshir · Oostakker, BE

Key dates

Filing date	Feb 18, 2019
Grant date	Sep 6, 2022
Priority date	—
Expiry date	Feb 18, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies and antigen binding fragments thereof which bind to the human CD70 protein with high affinity and display potent inhibition of tumour cell growth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.